Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including an | Immunology ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...

The company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.

WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...

Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...

Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...

samantha busch shows off incredible hair growth after battling alopecia areata, revealing resilience, treatments, and a ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

"Interestingly, sCD83's mode of action induces both the formation of new hair follicles and thus hair growth, and has the potential to redefine treatment approaches for hormone-induced androgenetic ...